Stay updated with breaking news from Preclinical Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Harvard researchers receive $1.2 million from CARB-X to develop enhanced oral antibiotics for drug-resistant bacteria listed by CDC.
EngineeringChapter1:VariousstagesofinnovativedrugresearchanddevelopmentTheresearchanddevelopmentofinnovativedrugsisa...
MONTPELLIER, France--(BUSINESS WIRE)--Jan 29, 2024--
Dublin, Jan. 16, 2024 (GLOBE NEWSWIRE) -- The
QPS Holdings LLC QPS a global contract research organization CRO that provides discovery preclinical bioanalysis clinical trials and clinical research services is reinforcing its focus on qualitative and quantitative bioanalysis of biotherapeutics in Europe.